Metraipolis › archive › dc_67698d42d648
Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis — Europe PMC PMID:41071055
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41071055
- DOI
- 10.1093/ecco-jcc/jjaf181
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T20:40:19.014Z
- SHA-256 of the archived text
d8e214627c7d3077ad4009c38571384a355ee9e8faa378c63e8f04184cff5fbb- Stable URL of this page
https://metraipolis.com/documento/dc_67698d42d648
How to cite
Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis — Europe PMC PMID:41071055 — Europe PMC (en), https://europepmc.org/article/MED/41071055 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_67698d42d648 (Metraipolis archive dc_67698d42d648, sha256 d8e214627c7d3077ad4009c38571384a355ee9e8faa378c63e8f04184cff5fbb)
BibTeX
@misc{dc67698d42d648,
title = {Glucagon-like peptide 1 receptor agonists and the clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis — Europe PMC PMID:41071055},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41071055},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_67698d42d648; sha256 d8e214627c7d3077ad4009c38571384a355ee9e8faa378c63e8f04184cff5fbb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41071055. Agents can read the archived copy with the MCP tool read_document.